S.C. Terapia S.A., Sun Pharmaceutical Industries Europe B.V.
PolandAll drugs from this manufacturer
-
The medicine is intended for adult patients with advanced non-small cell lung cancer (provided specific EGFR mutations are present) or in the case of metastatic pancreatic cancer (in which case it is used in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 25 mg ATC: L01XE03
-
The medicinal product is used in adult patients with advanced non-small cell lung cancer (provided that specific EGFR mutations are present) and in patients with metastatic pancreatic cancer (in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 100 mg ATC: L01XE03
-
The medicine is used in adult patients for the treatment of advanced non-small cell lung cancer (depending on the cancer cell mutations) and for the treatment of metastatic pancreatic cancer (in combination with gemcitabine).
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 150 mg ATC: L01XE03
-
The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn (painful burning in the chest reaching up to the throat) and acid regurgitation.
Dosage form: tablets, enteric-coated
Active substance Dosage pantoprazole 20 mg ATC: A02BC02
-
The medicine is used to treat bleeding from esophageal varices (bleeding from enlarged veins in a part of the digestive tract leading to the stomach).
Dosage form: solution for injection
Active substance Dosage terlipressin 0.1 mg/ml ATC: H01BA04